Movement Alert|UnitedHealth Rises 4.29% in Regular Trading, Bank of America Upgrades to Buy with $450 Target

Market Focus
Jun 04

On June 4, UnitedHealth rose 4.29% in regular trading, trading at $395.23/share, with trading volume of $533 million.

On the news front, Bank of America upgraded UnitedHealth from Neutral to Buy, raising its target price from $420 to $450, implying approximately 14% upside from the current level. The upgrade was primarily driven by improving medical cost trends and a favorable setup ahead of the Q2 earnings report. Additionally, Truist raised its target from $395 to $440 while maintaining a Buy rating, and Oppenheimer lifted its target from $405 to $420.

Fundamentally, April and May medical utilization data continued to trend favorably, suggesting that earnings improvement is sustainable rather than driven by one-time factors such as flu season or extreme weather. Meanwhile, subsidiary UnitedHealthcare announced plans to eliminate approximately two-thirds of prior authorization requirements for members under 18 by year-end, a move expected to enhance operational efficiency and patient satisfaction.

Within the Managed Health Care sector, peers also posted gains: Centene up 3.83%, Humana up 3.54%, Molina Healthcare up 3.19%, Elevance Health up 2.99%, and Alignment Healthcare up 5.26%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10